Therapy of the Overactive Bladder Syndrome

NCT01314781 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: solifenacin
PROCEDURE: PFMT and WBVT

Sponsor

Cantonal Hospital, Frauenfeld

Collaborators

[object Object]